Search

Search Results
Results 2991 - 3000 of 8494 for Skin Cancer
  • Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
  • News - 3 Oct 2025
    Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment.
  • Drug - 26 Sep 2025
    Consumer Medicine Information (CMI) about Rinvoq intended for persons living in Australia.
  • News - 3 May 2025
    Despite decades of public health messaging, Canadians are spending more time in the sun and using less sun protection – raising alarms among researchers as melanoma cases continue to climb.
  • Drug - 14 Apr 2025
    Consumer Medicine Information (CMI) about Cotellic intended for persons living in Australia.
  • Drug - 31 Mar 2025
    Consumer Medicine Information (CMI) about Caprelsa intended for persons living in Australia.
  • News - 13 Mar 2025
    Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.
  • Drug - 6 Mar 2025
    Consumer Medicine Information (CMI) about Imanib intended for persons living in Australia.
  • News - 5 Mar 2025
    This newly published analysis in Genes & Diseases sheds light on the crucial role of mechanosensitive adhesion G protein-coupled receptors (aGPCRs) in regulating biological processes and their...
  • News - 27 Jan 2025
    Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.